AI

Ainos, Inc.

AIMDTechnologyNASDAQ

Scientific & Technical Instruments

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$124,157
+499.0% YoY
Net Income
-$14.8M
+0.6% YoY
EBITDA
-$9.3M
+1.8% YoY
Free Cash Flow
$1.8M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 11 MACD Positive CrossoverHistogram +0.0179, positive momentum
Aug 10 MACD Positive CrossoverHistogram +0.0176, positive momentum
About Ainos, Inc.

Part of the technology sector, Ainos, Inc. (AIMD) is listed under Scientific & Technical Instruments. Valued at $11.8M, AIMD is a micro-cap name in its sector. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data.

Where AIMD stands vs its 150-day and 200-day moving averages

As of the August 11, 2026 close, AIMD finished 17.34% below its 150-day moving average ($1.73) and 25.52% below its 200-day moving average ($1.92). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AIMD overbought or oversold?

At the August 11, 2026 close, AIMD's RSI(14) was 40.9, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$11.8M
EPS$-2.49
Beta2.48
52W Change-55.7%
ROE-196.3%
Analysis

Ainos, Inc. carries $13.8M in total debt against $1.4M in cash reserves — debt is roughly 9.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $1.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -196.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been uneven over recent years, ranging from $595K to $124K.

A beta of 2.48 means AIMD is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Ainos, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Ainos, Inc.'s trajectory.

Links
More Technology stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms